MSN: COVID-19 vaccine study
UC faculty members involved in upcoming trial at Cincinnati Children's studying a new vaccine
Cincinnati Children's Hospital Medical Center will begin human trials for a COVID-19 vaccine in the upcoming weeks, and the screening process has already begun for people who want to participate.
"We are excited about this vaccine and think it has the possibility to decrease the risk of infection from COVID-19,” says Robert Frenck, MD, who will lead the study. Frenck is a professor of pediatrics at the UC College of Medicine and is medical director for the Division of Infectious Diseases and director of the Vaccine Research Center at Cincinnati Children's.
Watch the full WCPO-TV, Channel 9 story.
Carl Fichtenbaum, MD, professor in the Division of Infectious Diseases at the UC College of Medicine and a UC Health physician, applauded the efforts and expertise of his colleagues.
"It's a very cool study design that allows for flexibility," he says. "Cincinnati Children's is a powerhouse in vaccine development, going back to the days of Albert Sabin and the development of the polio vaccine."
Read the full MSN.com article.
Fichtenbaum also weighed in on other promising vaccine studies, like those coming from Massachusetts-based Moderna, Incorporated and another by researchers at Oxford University.
Watch the full WLWT-TV, Channel 5 story.
Featured photo/Colleen Kelley/UC Creative + Brand
Impact Lives Here
The University of Cincinnati is leading public urban universities into a new era of innovation and impact. Our faculty, staff and students are saving lives, changing outcomes and bending the future in our city's direction. Next Lives Here.
Stay up on all UC's COVID-19 stories, read more #UCtheGood content, or take a UC virtual visit and begin picturing yourself at an institution that inspires incredible stories.
Related Stories
Does the president's prescription drug site actually make medications affordable?
March 20, 2026
Local 12 turned to Erwin Erhardt, PhD, economics professor in UC’s Lindner College of Business for insights on direct-to-consumer drugs.
Fusion reactors may be key to uncovering dark matter
March 20, 2026
Popular Mechanics highlights a new study by University of Cincinnati physicist Jure Zupan that explains how fusion reactors might create subatomic particles associated with dark matter.
UC study reshapes understanding of interaction between organelles in animal cells
March 20, 2026
Research published in the journal Cell Reports led by the University of Cincinnati’s Jiajie Diao, PhD, reshapes the field’s fundamental understanding of lysosomal acidification.